Riley, P <br/><br/>
Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk.  [electronic resource] 

 -  Cardiovascular therapeutics  2009 
 - 216-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1755-5922 
<br/><br/><label>Standard No.: </label>10.1111/j.1755-5922.2009.00088.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Chemical and Drug Induced Liver Injury--epidemiology<br/>Drug Prescriptions<br/>Fatty Liver--drug therapy<br/>Guidelines as Topic<br/>Hemodynamics--drug effects<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Risk